KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Assets Average: 2012-2024

Historic Assets Average for Supernus Pharmaceuticals (SUPN) over the last 13 years, with Dec 2024 value amounting to $1.3 billion.

  • Supernus Pharmaceuticals' Assets Average rose 5.40% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 5.40%. This contributed to the annual value of $1.3 billion for FY2024, which is 11.22% down from last year.
  • Supernus Pharmaceuticals' Assets Average amounted to $1.3 billion in FY2024, which was down 11.22% from $1.5 billion recorded in FY2023.
  • In the past 5 years, Supernus Pharmaceuticals' Assets Average registered a high of $1.7 billion during FY2022, and its lowest value of $1.3 billion during FY2024.
  • For the 3-year period, Supernus Pharmaceuticals' Assets Average averaged around $1.5 billion, with its median value being $1.5 billion (2023).
  • Its Assets Average has fluctuated over the past 5 years, first grew by 24.61% in 2020, then fell by 12.13% in 2023.
  • Supernus Pharmaceuticals' Assets Average (Yearly) stood at $1.3 billion in 2020, then grew by 19.85% to $1.6 billion in 2021, then increased by 6.21% to $1.7 billion in 2022, then declined by 12.13% to $1.5 billion in 2023, then dropped by 11.22% to $1.3 billion in 2024.